About: Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.66 (+153.23%)
TCRT NASDAQ Alaunos Therapeutics Inc
Alaunos Therapeutics Inc share price
TCRT price activity
Last Price
$3.890
Change (24hr)
2.84 USD (270.68%)
Volume
183.28M
Volume (4w avg)
-
Open
$1.73
Day Range
$1.73 - $3.91
Previous Close
$1.05
Last Trade
13 Oct, 4:24 pm GMT+0
Delayed
13 Oct, 4:24 pm GMT+0
TCRT price performance
Delayed
13 Oct, 4:24 pm GMT+0
TCRT Market Signals